Souders Financial Advisors cut its stake in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 1.8% during the 3rd quarter, Holdings Channel reports. The fund owned 133,465 shares of the company’s stock after selling 2,428 shares during the period. Procter & Gamble comprises approximately 3.2% of Souders Financial Advisors’ investment portfolio, making the stock its 7th largest position. Souders Financial Advisors’ holdings in Procter & Gamble were worth $23,116,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors and hedge funds have also bought and sold shares of PG. Acorn Creek Capital LLC boosted its holdings in Procter & Gamble by 2.8% in the third quarter. Acorn Creek Capital LLC now owns 2,170 shares of the company’s stock valued at $376,000 after purchasing an additional 59 shares during the last quarter. Patrick M Sweeney & Associates Inc. boosted its holdings in Procter & Gamble by 1.1% in the third quarter. Patrick M Sweeney & Associates Inc. now owns 5,561 shares of the company’s stock valued at $963,000 after purchasing an additional 59 shares during the last quarter. Alera Investment Advisors LLC boosted its holdings in Procter & Gamble by 1.2% in the first quarter. Alera Investment Advisors LLC now owns 5,007 shares of the company’s stock valued at $812,000 after purchasing an additional 60 shares during the last quarter. Hudson Value Partners LLC raised its position in shares of Procter & Gamble by 4.1% in the second quarter. Hudson Value Partners LLC now owns 1,516 shares of the company’s stock worth $250,000 after acquiring an additional 60 shares during the period. Finally, Traveka Wealth LLC raised its position in shares of Procter & Gamble by 1.7% in the third quarter. Traveka Wealth LLC now owns 3,554 shares of the company’s stock worth $616,000 after acquiring an additional 60 shares during the period. 65.77% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
PG has been the subject of several research analyst reports. Wolfe Research upgraded shares of Procter & Gamble to a “strong-buy” rating in a research report on Friday, August 23rd. Barclays downgraded shares of Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price objective for the company. in a report on Monday, September 30th. Royal Bank of Canada reiterated a “sector perform” rating and issued a $164.00 price objective on shares of Procter & Gamble in a report on Monday, October 21st. Morgan Stanley increased their price target on shares of Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a research note on Monday, October 21st. Finally, Stifel Nicolaus increased their price target on shares of Procter & Gamble from $157.00 to $161.00 and gave the company a “hold” rating in a research note on Monday, July 22nd. Nine analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $177.00.
Procter & Gamble Price Performance
Shares of NYSE:PG opened at $165.84 on Wednesday. The company’s fifty day moving average price is $170.79 and its 200 day moving average price is $168.29. The Procter & Gamble Company has a 12 month low of $142.50 and a 12 month high of $177.94. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55. The firm has a market capitalization of $390.56 billion, a P/E ratio of 28.59, a P/E/G ratio of 3.59 and a beta of 0.42.
Procter & Gamble (NYSE:PG – Get Free Report) last announced its quarterly earnings results on Friday, October 18th. The company reported $1.93 EPS for the quarter, topping the consensus estimate of $1.90 by $0.03. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The firm had revenue of $21.74 billion for the quarter, compared to analyst estimates of $21.99 billion. During the same period last year, the business earned $1.83 EPS. Procter & Gamble’s revenue for the quarter was down .6% compared to the same quarter last year. As a group, sell-side analysts predict that The Procter & Gamble Company will post 6.94 earnings per share for the current fiscal year.
Procter & Gamble Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be given a dividend of $1.0065 per share. This represents a $4.03 annualized dividend and a yield of 2.43%. The ex-dividend date is Friday, October 18th. Procter & Gamble’s payout ratio is currently 69.48%.
Insiders Place Their Bets
In other Procter & Gamble news, CEO Jon R. Moeller sold 31,797 shares of the firm’s stock in a transaction on Tuesday, August 20th. The shares were sold at an average price of $169.22, for a total transaction of $5,380,688.34. Following the transaction, the chief executive officer now directly owns 300,777 shares of the company’s stock, valued at approximately $50,897,483.94. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. In other news, COO Shailesh Jejurikar sold 10,623 shares of Procter & Gamble stock in a transaction dated Tuesday, August 20th. The shares were sold at an average price of $169.22, for a total value of $1,797,624.06. Following the sale, the chief operating officer now owns 23,890 shares of the company’s stock, valued at $4,042,665.80. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Jon R. Moeller sold 31,797 shares of Procter & Gamble stock in a transaction dated Tuesday, August 20th. The shares were sold at an average price of $169.22, for a total transaction of $5,380,688.34. Following the completion of the sale, the chief executive officer now directly owns 300,777 shares in the company, valued at approximately $50,897,483.94. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 313,597 shares of company stock valued at $53,268,499. Insiders own 0.18% of the company’s stock.
Procter & Gamble Profile
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Featured Articles
- Five stocks we like better than Procter & Gamble
- How Investors Can Find the Best Cheap Dividend Stocks
- 3 Solar Stocks at Bargain Prices: Big Opportunities Ahead
- Investing in Commodities: What Are They? How to Invest in Them
- Is Bitcoin’s Trump Card a Boom or Bust?
- Industrial Products Stocks Investing
- Cloudflare Is a Solid Buy for 2025
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.